| |
|
|
|
|
|
|
Plasma Medicine
Back to Plasma Medicine
3. Dermatologische Klinik und Poliklinik der Universität Regensburg
The Department of Dermatology at the University Hospital Regensburg joined the
collaboration in 2009. After the first promising results of decreasing the
bacterial load on chronic wounds and thereby achieving faster wound healing by
low-temperature Argon-plasma therapy, a phase II study was started at the
University Hospital Regensburg. To examine the antipruritic effect of cold
plasma, patients with pruritic diseases were also included in the clinical trial.
In this study, randomized wounds or itching skin are treated for 2 min daily
with the plasma device MicroPlaSter Beta, built and tested by ADTEC
Plasma Technology Co. Ltd., Hiroshima/London. This plasma application is
implemented as an 'add-on-therapy' in addition to the standard therapy.
Particularly in dermatology, a wide therapeutic potential of cold atmospheric
plasma therapy is expected because of its physical properties, such as fast and
efficient disinfection, treatment of chronic or acute wounds, skin infections
and skin regeneration. Multidisciplinary research – from bench to bedside –
is essential in instituting plasma application into medical practice.
Figure: Treatment of a patient using the MicroPlaSter Beta.
Read more
- Chronic wound treatment
|
|
|
|
| |
|
|
